Cargando…

Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and Obesity

Our aim was to analyze how type 2 diabetes and obesity influence quality of life (QoL) and coping in patients with nonalcoholic fatty liver disease (NAFLD), and which coping strategies predict diabetic or obese participants’ QoL. QoL (SF-12, CLDQ-NAFLD) and coping strategies (COPE-28) were evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funuyet-Salas, Jesús, Pérez-San-Gregorio, María Ángeles, Martín-Rodríguez, Agustín, Romero-Gómez, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036804/ https://www.ncbi.nlm.nih.gov/pubmed/33800585 http://dx.doi.org/10.3390/ijerph18073503

Ejemplares similares

Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
por: Funuyet-Salas, Jesús, et al.
Publicado: (2021)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Significance of Post-Traumatic Growth and Mental Health for Coping in Multiple Sclerosis Caregivers
por: Gil-González, Irene, et al.
Publicado: (2023)

Relationship Between Self-Perceived Health, Vitality, and Posttraumatic Growth in Liver Transplant Recipients
por: Funuyet-Salas, Jesús, et al.
Publicado: (2019)

Coping Strategies in Liver Transplant Recipients and Caregivers According to Patient Posttraumatic Growth
por: Pérez-San-Gregorio, M. Ángeles, et al.
Publicado: (2017)

Coping Strategies Furthering Post-Traumatic Growth in Multiple Sclerosis: A Longitudinal Study
por: Gil-González, Irene, et al.
Publicado: (2022)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis
por: Gómez-Pérez, Ana María, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
por: Romero-Gomez, Manuel, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt, Steven J, et al.
Publicado: (2014)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
por: Divella, Rosa, et al.
Publicado: (2019)

Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review
por: Hashem, Anas, et al.
Publicado: (2021)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
por: Ristic-Medic, Danijela, et al.
Publicado: (2022)

Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis
por: Kang, Seong Hee, et al.
Publicado: (2023)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Metabolic status indicators and influencing factors in non-obese, non-centrally obese nonalcoholic fatty liver disease
por: Huang, Zhipeng, et al.
Publicado: (2023)

The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial
por: Marin-Alejandre, Bertha Araceli, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in adolescents with phenylketonuria
por: Silveira, Adriana Márcia, et al.
Publicado: (2022)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents
por: Ued, Fábio da Veiga, et al.
Publicado: (2013)

The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease
por: Feldman, Alexandra, et al.
Publicado: (2015)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
por: Ferolla, Silvia M., et al.
Publicado: (2014)

The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity
por: Pacifico, Lucia, et al.
Publicado: (2016)

Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
por: Wasilewska, Natalia, et al.
Publicado: (2018)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
por: Zhang, Shujun, et al.
Publicado: (2017)

Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease
por: Machado, M V, et al.
Publicado: (2016)

Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer
por: Zhu, Chan-Yan, et al.
Publicado: (2019)

Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity
por: Peng, Luting, et al.
Publicado: (2021)

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
por: Song, Wolhwa, et al.
Publicado: (2023)

Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease
por: Jin, Li-ting, et al.
Publicado: (2023)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p910ogrhe99m2ebt2i5j2fvro0